These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7759785)

  • 21. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection.
    Bergh C; Lindenberg S;
    Hum Reprod; 2012 Dec; 27(12):3467-73. PubMed ID: 23019296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of estrogen support during the luteal phase of in vitro fertilization-embryo transplant cycles: a comparative study between progesterone alone and estrogen and progesterone support.
    Lewin A; Benshushan A; Mezker E; Yanai N; Schenker JG; Goshen R
    Fertil Steril; 1994 Jul; 62(1):121-5. PubMed ID: 8005275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol.
    Fatemi HM; Camus M; Kolibianakis EM; Tournaye H; Papanikolaou EG; Donoso P; Devroey P
    Fertil Steril; 2007 Mar; 87(3):504-8. PubMed ID: 17140572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study.
    Chakravarty BN; Shirazee HH; Dam P; Goswami SK; Chatterjee R; Ghosh S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):416-20. PubMed ID: 16213136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts.
    Shapiro DB; Pappadakis JA; Ellsworth NM; Hait HI; Nagy ZP
    Hum Reprod; 2014 Aug; 29(8):1706-11. PubMed ID: 24847018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone.
    Buvat J; Marcolin G; Guittard C; Herbaut JC; Louvet AL; Dehaene JL
    Fertil Steril; 1990 Mar; 53(3):490-4. PubMed ID: 2407565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crinone Gel for Luteal Phase Support in Frozen-Thawed Embryo Transfer Cycles: A Prospective Randomized Clinical Trial in the Chinese Population.
    Wang Y; He Y; Zhao X; Ji X; Hong Y; Wang Y; Zhu Q; Xu B; Sun Y
    PLoS One; 2015; 10(7):e0133027. PubMed ID: 26222435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trial.
    Dal Prato L; Bianchi L; Cattoli M; Tarozzi N; Flamigni C; Borini A
    Reprod Biomed Online; 2008 Mar; 16(3):361-7. PubMed ID: 18339258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmatic estradiol concentration in the mid-luteal phase is a good prognostic factor for clinical and ongoing pregnancies, during stimulated cycles of in vitro fertilization.
    Florêncio RS; Meira MSB; Cunha MVD; Camarço MNCR; Castro EC; Finotti MCCF; Oliveira VA
    JBRA Assist Reprod; 2018 Mar; 22(1):8-14. PubMed ID: 29338136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the addition of recombinant luteinizing hormone to progesterone for luteal supplementation improve IVF outcomes in high-responder patients? A preliminary randomized controlled study.
    Seckin B; Ozaksit G; Oruc AS; Yilmaz N
    J Reprod Med; 2014; 59(5-6):321-6. PubMed ID: 24937976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles: a randomized clinical trial.
    Zarei A; Sohail P; Parsanezhad ME; Alborzi S; Samsami A; Azizi M
    Arch Gynecol Obstet; 2017 Jan; 295(1):239-246. PubMed ID: 27761732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intramuscular versus vaginal progesterone in assisted reproduction: a comparative study.
    Perino M; Brigandì FG; Abate FG; Costabile L; Balzano E; Abate A
    Clin Exp Obstet Gynecol; 1997; 24(4):228-31. PubMed ID: 9478327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone vaginal capsule versus vaginal gel for luteal support in normoresponder women undergoing long agonist IVF/ICSI cycles.
    Gün İ; Özdamar Ö; Şahin S; Çetingöz E; Sofuoğlu K
    Ginekol Pol; 2016; 87(5):372-7. PubMed ID: 27304654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 17 alpha-hydroxyprogesterone caproate versus intravaginal progesterone in IVF-embryo transfer cycles: a prospective randomized study.
    Unfer V; Casini ML; Costabile L; Gerli S; Baldini D; Di Renzo GC
    Reprod Biomed Online; 2004 Jul; 9(1):17-21. PubMed ID: 15257811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Luteal phase support and severe ovarian hyperstimulation syndrome.
    McClure N; Leya J; Radwanska E; Rawlins R; Haning RV
    Hum Reprod; 1992 Jul; 7(6):758-64. PubMed ID: 1500471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial.
    Fatemi HM; Kolibianakis EM; Camus M; Tournaye H; Donoso P; Papanikolaou E; Devroey P
    Hum Reprod; 2006 Oct; 21(10):2628-32. PubMed ID: 16857887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of luteal support with human chorionic gonadotrophin or progesterone on the daily progesterone profile after different types of ovarian stimulation.
    Nikkanen V; Kresanov I; Mäkinen J; Vuorento T
    Hum Reprod; 1992 Mar; 7(3):333-6. PubMed ID: 1587937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Luteal phase support with estrogen in addition to progesterone increases pregnancy rates in in vitro fertilization cycles with poor response to gonadotropins.
    Kutlusoy F; Guler I; Erdem M; Erdem A; Bozkurt N; Biberoglu EH; Biberoglu KO
    Gynecol Endocrinol; 2014 May; 30(5):363-6. PubMed ID: 24517720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.